Related Experiment Video
Updated: Oct 8, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors
Erez Marcusohn1, Ofer Kobo2, Maria Postnikov1
1Department of Cardiology, Rambam Health Care Campus Haifa, Israel.
Insights
Men with rapid heart rates during atrial fibrillation (AF) or atrial flutter (AFL) are more prone to reduced left ventricular ejection fraction (LVEF). Prosthetic valve history also increases LVEF reduction risk during AF/AFL.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiomyopathy Research
Background:
- Atrial fibrillation (AF)-induced cardiomyopathy diagnosis is complex, requiring exclusion of other causes and assessment of left ventricular (LV) function recovery post-sinus rhythm restoration.
- Predicting systolic dysfunction in patients with atrial tachyarrhythmia is crucial for timely intervention.
Purpose of the Study:
- To identify clinical and echocardiographic predictors of developing cardiomyopathy with systolic dysfunction in patients experiencing atrial tachyarrhythmia.
- To understand risk factors associated with left ventricular ejection fraction (LVEF) reduction during paroxysmal AF or atrial flutter (AFL).
Main Methods:
- Retrospective analysis of 482 patients with baseline preserved LVEF (>50%) in sinus rhythm.
- Comparison of patients with reduced LVEF versus preserved LVEF during precardioversion transesophageal echocardiography for AF/AFL.
- Identification of clinical and echocardiographic parameters associated with LVEF deterioration.
Main Results:
- 17% of patients (80/482) experienced reduced LVEF during AF/AFL.
- Male sex and rapid ventricular response during AF/AFL were significantly associated with reduced LVEF.
- History of prosthetic valves, tricuspid regurgitation, and right ventricular dysfunction were identified as risk factors for LVEF reduction.
Conclusions:
- Male patients with rapid ventricular response during paroxysmal AF or AFL are at higher risk for LVEF reduction.
- Patients with prosthetic valves are also susceptible to LVEF reduction during AF/AFL.
- Tricuspid regurgitation and right ventricular dysfunction may suggest prolonged AF/AFL with associated LVEF decline.
Abstract:
Background: Diagnosis of AF-induced cardiomyopathy can be challenging and relies on ruling out other causes of cardiomyopathy and, after restoration of sinus rhythm, recovery of left ventricular (LV) function. The aim of this study was to identify clinical and echocardiographic predictors for developing cardiomyopathy with systolic dysfunction in patients with atrial tachyarrhythmia. Methods: This retrospective study was conducted in a large tertiary care centre and compared patients who experienced deterioration of LV ejection fraction (EF) during paroxysmal AF, demonstrated by precardioversion transoesophageal echocardiography with patients with preserved LV function during AF. All patients had documented preserved LVEF at baseline (EF >50%) while in sinus rhythm. Results: Of 482 patients included in the final analysis, 80 (17%) had reduced and 402 (83%) had preserved LV function during the precardioversion transoesophageal echocardiography. Patients with reduced LVEF were more likely to be men and to have a more rapid ventricular response during AF or atrial flutter (AFL). A history of prosthetic valves was also identified as a risk factor for reduced LVEF. Patients with reduced LVEF also had higher incidence of tricuspid regurgitation and right ventricular dysfunction. Conclusion: In 'real-world' experience, male patients with rapid ventricular response during paroxysmal AF or AFL are more prone to LVEF reduction. Patients with prosthetic valves are also at risk for LVEF reduction during AF/AFL. Finally, tricuspid regurgitation and right ventricular dysfunction may indicate relatively long-standing AF with an associated reduction in LVEF.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure II: Pathophysiology
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Regurgitation I: Introduction

